[{"from": "human", "value": "Create a molecule that satisfies the conditions outlined in the description. The molecule is under investigation in clinical trial NCT00493454 (Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas)."}, {"from": "gpt", "value": "[111In]"}]